0000950170-24-064274.txt : 20240523 0000950170-24-064274.hdr.sgml : 20240523 20240523215437 ACCESSION NUMBER: 0000950170-24-064274 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240522 FILED AS OF DATE: 20240523 DATE AS OF CHANGE: 20240523 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Hughes-Wilson Alexandra CENTRAL INDEX KEY: 0002005875 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38452 FILM NUMBER: 24980680 MAIL ADDRESS: STREET 1: C/O MEREO BIOPHARMA STREET 2: 1 CAVENDISH PLACE CITY: LONDON STATE: X0 ZIP: W1G 0QF ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Mereo BioPharma Group plc CENTRAL INDEX KEY: 0001719714 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: X0 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE CAVENDISH PLACE STREET 2: FOURTH FLOOR CITY: LONDON STATE: X0 ZIP: W1G0QF BUSINESS PHONE: 4403330237300 MAIL ADDRESS: STREET 1: ONE CAVENDISH PLACE STREET 2: FOURTH FLOOR CITY: LONDON STATE: X0 ZIP: W1G0QF FORMER COMPANY: FORMER CONFORMED NAME: Mereo Biopharma Group plc DATE OF NAME CHANGE: 20171016 4 1 ownership.xml 4 X0508 4 2024-05-22 0001719714 Mereo BioPharma Group plc MREO 0002005875 Hughes-Wilson Alexandra C/O MEREO BIOPHARMA GROUP PLC 4TH FLOOR, ONE CAVENDISH PLACE LONDON X0 W1G 0QF UNITED KINGDOM false true false false See Remarks false American Depositary Shares representing Ordinary Shares 2024-05-22 4 M false 93333 1.4 A 100983 D American Depositary Shares representing Ordinary Shares 2024-05-22 4 S false 50350 2.99 D 58633 D American Depositary Shares representing Ordinary Shares 2024-05-22 4 F false 42983 1.40 D 7650 D American Depositary Shares representing Ordinary Shares 2024-05-22 4 M false 75000 1.01 A 82650 D American Depositary Shares representing Ordinary Shares 2024-05-22 4 S false 50082 2.94 D 32568 D American Depositary Shares representing Ordinary Shares 2024-05-22 4 F false 24918 1.01 D 7650 D Share Options (Right to buy) 1.40 2024-05-22 4 M false 93333 1.40 D 2032-01-14 American Depositary Shares 93333 0 D Share Options (Right to buy) 1.01 2024-05-22 4 M false 75000 1.01 D 2033-01-25 American Depositary Shares 75000 0 D Each American Depositary Share ("ADS") represents five ordinary shares, nominal value GBP 0.003 per ordinary share, of the Issuer. Ms. Hughes-Wilson sold a total of 100,432 ADSs solely to pay a tax obligation, and all proceeds are being used for such taxes. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $2.88 to $3.04, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges 160,000 options were issued on 01/14/2022 and 25% of the shares underlying this award became exercisable on January 14, 2023, with the remainder vesting in equal monthly installments thereafter. 240,000 options were issued on 01/25/2023 and 25% of the shares underlying this award became exercisable on January 25, 2024, with the remainder vesting in equal monthly installments thereafter. Chief Patient Access and Commercial Planning /s/ Christine Fox, by power of attorney 2024-05-23